A Phase 1/2 Multicenter Dose Escalation and Expansion Study Of NKTR-214 In Subjects With Locally Advanced Or Metastatic Solid Tumors
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:July 29, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:July 29, 2021Completed
Condition(s):Advanced or Metastatic Biliary Tract Cancer; Advanced or Metastatic Solid TumorsLast Updated:June 28, 2018Completed
Condition(s):Locally Advanced or Metastatic Solid TumorsLast Updated:February 22, 2024Recruiting
Condition(s):Locally Advanced/Metastatic Solid TumorsLast Updated:November 9, 2023Active, not recruiting
Condition(s):Advanced or Metastatic Solid TumorsLast Updated:September 7, 2012Completed
Condition(s):Locally Advanced or Metastatic Solid TumorsLast Updated:December 8, 2023Recruiting
Condition(s):Locally Advanced or Metastatic Solid TumorsLast Updated:March 5, 2024Not yet recruiting
Condition(s):Locally Advanced or Metastatic Solid TumorsLast Updated:October 27, 2022Recruiting
Condition(s):Locally Advanced Unresectable or Metastatic Solid TumorsLast Updated:December 12, 2022Not yet recruiting
Condition(s):Advanced/Metastatic Solid Tumors or LymphomaLast Updated:August 9, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.